146 related articles for article (PubMed ID: 30654714)
1. Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry.
Hurst Z; Liyanarachchi S; He H; Brock P; Sipos J; Nabhan F; Kebebew E; Green P; Cote GJ; Sherman S; Walker CJ; Chang YS; Xue S; Hollingsworth B; Li W; Genutis L; Menq E; de la Chapelle A; Jhiang SM
Thyroid; 2019 Apr; 29(4):530-539. PubMed ID: 30654714
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases.
Sabra MM; Dominguez JM; Grewal RK; Larson SM; Ghossein RA; Tuttle RM; Fagin JA
J Clin Endocrinol Metab; 2013 May; 98(5):E829-36. PubMed ID: 23533233
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes.
Simões-Pereira J; Saramago A; Rodrigues R; Pojo M; Pires C; Horta M; López-Presa D; Rito M; Cabrera R; Ferreira TC; Leite V; Cavaco BM
Endocrine; 2024 May; 84(2):625-634. PubMed ID: 38102497
[TBL] [Abstract][Full Text] [Related]
4. Do Molecular Profiles of Primary
Gomes-Lima CJ; Shobab L; Wu D; Ylli D; Bikas A; McCoy M; Feldman R; Lee W; Rao SN; Jensen K; Vasko V; Castro LC; Jonklaas J; Wartofsky L; Burman KD
Front Endocrinol (Lausanne); 2021; 12():623182. PubMed ID: 33716974
[TBL] [Abstract][Full Text] [Related]
5. Presumed Pathogenic Germ Line and Somatic Variants in African American Thyroid Cancer.
Hurst ZA; Liyanarachchi S; Brock P; He H; Nabhan F; Veloski C; Toland AE; Ringel MD; Jhiang SM
Thyroid; 2024 Mar; 34(3):378-387. PubMed ID: 38062767
[No Abstract] [Full Text] [Related]
6. Robust Thyroid Gene Expression and Radioiodine Uptake Induced by Simultaneous Suppression of BRAF V600E and Histone Deacetylase in Thyroid Cancer Cells.
Cheng W; Liu R; Zhu G; Wang H; Xing M
J Clin Endocrinol Metab; 2016 Mar; 101(3):962-71. PubMed ID: 26751190
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers.
Toro-Tobon D; Morris JC; Hilger C; Peskey C; Durski JM; Ryder M
Thyroid; 2024 Jan; 34(1):70-81. PubMed ID: 37917101
[No Abstract] [Full Text] [Related]
8. Characterizing Genetic Alterations Related to Radioiodine Avidity in Metastatic Thyroid Cancer.
Mu Z; Zhang X; Sun D; Sun Y; Shi C; Ju G; Kai Z; Huang L; Chen L; Liang J; Lin Y
J Clin Endocrinol Metab; 2024 Apr; 109(5):1231-1240. PubMed ID: 38060243
[TBL] [Abstract][Full Text] [Related]
9. Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers.
Syed AR; Gorana A; Nohr E; Yuan XK; Amin MASc P; Ghaznavi S; Lamb D; McIntyre J; Eszlinger M; Paschke R
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38642578
[TBL] [Abstract][Full Text] [Related]
10. [The relationship between differentially expressed thyroid cancer genes and clinical characteristics in metastatic children and adolescents].
Pan YJ; Ju GD; Mu ZZ; Sun YQ; Sun D; Liang J; Lin YS
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1837-1843. PubMed ID: 38782752
[No Abstract] [Full Text] [Related]
11. Characteristics and immune checkpoint status of radioiodine-refractory recurrent papillary thyroid carcinomas from Ukrainian Chornobyl Tissue Bank donors.
Bogdanova T; Rogounovitch TI; Zurnadzhy L; Mitsutake N; Tronko M; Ito M; Bolgov M; Chernyshov S; Gulevatyi S; Masiuk S; Yamashita S; Saenko VA
Front Endocrinol (Lausanne); 2023; 14():1343848. PubMed ID: 38260161
[TBL] [Abstract][Full Text] [Related]
12. Haplotype-resolved germline and somatic alterations in renal medullary carcinomas.
Tan KT; Kim H; Carrot-Zhang J; Zhang Y; Kim WJ; Kugener G; Wala JA; Howard TP; Chi YY; Beroukhim R; Li H; Ha G; Alper SL; Perlman EJ; Mullen EA; Hahn WC; Meyerson M; Hong AL
Genome Med; 2021 Jul; 13(1):114. PubMed ID: 34261517
[TBL] [Abstract][Full Text] [Related]
13. Racial Disparities in the Molecular Landscape of Cancer.
Heath EI; Lynce F; Xiu J; Ellerbrock A; Reddy SK; Obeid E; Liu SV; Bollig-Fischer A; Separovic D; Vanderwalde A
Anticancer Res; 2018 Apr; 38(4):2235-2240. PubMed ID: 29599344
[TBL] [Abstract][Full Text] [Related]
14. Mapping the 17q12-21.1 Locus for Variants Associated with Early-Onset Asthma in African Americans.
Gui H; Levin AM; Hu D; Sleiman P; Xiao S; Mak ACY; Yang M; Barczak AJ; Huntsman S; Eng C; Hochstadt S; Zhang E; Whitehouse K; Simons S; Cabral W; Takriti S; Abecasis G; Blackwell TW; Kang HM; Nickerson DA; Germer S; Lanfear DE; Gilliland F; Gauderman WJ; Kumar R; Erle DJ; Martinez FD; Hakonarson H; Burchard EG; Williams LK
Am J Respir Crit Care Med; 2021 Feb; 203(4):424-436. PubMed ID: 32966749
[No Abstract] [Full Text] [Related]
15. Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer.
Wallner LP; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Lubitz C; Hawley ST; Haymart MR
J Clin Endocrinol Metab; 2021 May; 106(6):e2402-e2412. PubMed ID: 33687063
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer clinical and molecular analysis of racial disparities.
Lara OD; Wang Y; Asare A; Xu T; Chiu HS; Liu Y; Hu W; Sumazin P; Uppal S; Zhang L; Rauh-Hain JA; Sood AK
Cancer; 2020 Feb; 126(4):800-807. PubMed ID: 31730714
[TBL] [Abstract][Full Text] [Related]
17. Fas promoter polymorphisms: genetic predisposition to sarcoidosis in African-Americans.
Wasfi YS; Silveira LJ; Jonth A; Hokanson JE; Fingerlin T; Sato H; Parsons CE; Lympany P; Welsh K; du Bois RM; Newman LS; Maier LA;
Tissue Antigens; 2008 Jul; 72(1):39-48. PubMed ID: 18588573
[TBL] [Abstract][Full Text] [Related]
18. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.
Kittles RA; Baffoe-Bonnie AB; Moses TY; Robbins CM; Ahaghotu C; Huusko P; Pettaway C; Vijayakumar S; Bennett J; Hoke G; Mason T; Weinrich S; Trent JM; Collins FS; Mousses S; Bailey-Wilson J; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD
J Med Genet; 2006 Jun; 43(6):507-11. PubMed ID: 16155194
[TBL] [Abstract][Full Text] [Related]
19. Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African Americans.
Koboldt DC; Kanchi KL; Gui B; Larson DE; Fulton RS; Isaacs WB; Kraja A; Borecki IB; Jia L; Wilson RK; Mardis ER; Kibel AS
Cancer Epidemiol Biomarkers Prev; 2016 Nov; 25(11):1456-1463. PubMed ID: 27486019
[TBL] [Abstract][Full Text] [Related]
20. Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.
Moore A; Bar Y; Maurice-Dror C; Finkel I; Goldvaser H; Dudnik E; Goldstein DA; Gordon N; Billan S; Gutfeld O; Wolf I; Popovtzer A
Medicine (Baltimore); 2021 Jun; 100(25):e26388. PubMed ID: 34160418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]